D
MedMira Inc.
MMIRF
$0.0131
-$0.0769-85.44%
D
Sell
2/20/2025Upgraded
MedMira Inc. (MMIRF) was upgraded to D- from E+ on 2/20/2025 due to an increase in the volatility index and valuation index.
MedMira Inc. (MMIRF) was upgraded to D- from E+ on 2/20/2025 due to an increase in the volatility index and valuation index.
E
Sell
2/5/2025Downgrade
MedMira Inc. (MMIRF) was downgraded to E+ from D- on 2/5/2025 due to a decline in the volatility index, total return index and valuation index.
MedMira Inc. (MMIRF) was downgraded to E+ from D- on 2/5/2025 due to a decline in the volatility index, total return index and valuation index.
D
Sell
1/21/2025Upgraded
MedMira Inc. (MMIRF) was upgraded to D- from E+ on 1/21/2025 due to an increase in the total return index and volatility index.
MedMira Inc. (MMIRF) was upgraded to D- from E+ on 1/21/2025 due to an increase in the total return index and volatility index.
E
Sell
1/6/2025Downgrade
MedMira Inc. (MMIRF) was downgraded to E+ from D- on 1/6/2025 due to a decline in the volatility index, total return index and growth index. Operating cash flow declined 31.19% from -$556.9 to -$730.6, EBIT declined 23.34% from -$628.5 to -$775.2, and total revenue declined 4.03% from $47.1 to $45.2.
MedMira Inc. (MMIRF) was downgraded to E+ from D- on 1/6/2025 due to a decline in the volatility index, total return index and growth index. Operating cash flow declined 31.19% from -$556.9 to -$730.6, EBIT declined 23.34% from -$628.5 to -$775.2, and total revenue declined 4.03% from $47.1 to $45.2.
D
Sell
12/27/2024Upgraded
MedMira Inc. (MMIRF) was upgraded to D- from E+ on 12/27/2024 due to an increase in the total return index, volatility index and solvency index.
MedMira Inc. (MMIRF) was upgraded to D- from E+ on 12/27/2024 due to an increase in the total return index, volatility index and solvency index.
E
Sell
10/28/2024Downgrade
MedMira Inc. (MMIRF) was downgraded to E+ from D- on 10/28/2024 due to a decline in the volatility index and valuation index.
MedMira Inc. (MMIRF) was downgraded to E+ from D- on 10/28/2024 due to a decline in the volatility index and valuation index.
D
Sell
9/4/2024Upgraded
MedMira Inc. (MMIRF) was upgraded to D- from E+ on 9/4/2024 due to an increase in the volatility index and valuation index.
MedMira Inc. (MMIRF) was upgraded to D- from E+ on 9/4/2024 due to an increase in the volatility index and valuation index.
E
Sell
8/20/2024Downgrade
MedMira Inc. (MMIRF) was downgraded to E+ from D- on 8/20/2024 due to a noticeable decline in the growth index and volatility index. Operating cash flow declined 75.08% from -$400 to -$700.3, total revenue declined 45.41% from $110.1 to $60.1, and EBIT declined 17.35% from -$378.7 to -$444.4.
MedMira Inc. (MMIRF) was downgraded to E+ from D- on 8/20/2024 due to a noticeable decline in the growth index and volatility index. Operating cash flow declined 75.08% from -$400 to -$700.3, total revenue declined 45.41% from $110.1 to $60.1, and EBIT declined 17.35% from -$378.7 to -$444.4.
D
Sell
2/20/2024Upgraded
MedMira Inc. (MMIRF) was upgraded to D- from E+ on 2/20/2024 due to an increase in the total return index and volatility index.
MedMira Inc. (MMIRF) was upgraded to D- from E+ on 2/20/2024 due to an increase in the total return index and volatility index.
E
Sell
1/24/2024Downgrade
MedMira Inc. (MMIRF) was downgraded to E+ from D- on 1/24/2024 due to a decline in the volatility index.
MedMira Inc. (MMIRF) was downgraded to E+ from D- on 1/24/2024 due to a decline in the volatility index.
D
Sell
1/9/2024Upgraded
MedMira Inc. (MMIRF) was upgraded to D- from E+ on 1/9/2024 due to an increase in the volatility index, valuation index and solvency index. The quick ratio increased from 0.09 to 0.14.
MedMira Inc. (MMIRF) was upgraded to D- from E+ on 1/9/2024 due to an increase in the volatility index, valuation index and solvency index. The quick ratio increased from 0.09 to 0.14.
E
Sell
4/26/2023Downgrade
MedMira Inc. (MMIRF) was downgraded to E+ from D- on 4/26/2023 due to a decline in the volatility index, total return index and valuation index.
MedMira Inc. (MMIRF) was downgraded to E+ from D- on 4/26/2023 due to a decline in the volatility index, total return index and valuation index.
D
Sell
3/29/2023Upgraded
MedMira Inc. (MMIRF) was upgraded to D- from E+ on 3/29/2023 due to an increase in the valuation index.
MedMira Inc. (MMIRF) was upgraded to D- from E+ on 3/29/2023 due to an increase in the valuation index.
E
Sell
3/14/2023Downgrade
MedMira Inc. (MMIRF) was downgraded to E+ from D on 3/14/2023 due to a decline in the valuation index and volatility index.
MedMira Inc. (MMIRF) was downgraded to E+ from D on 3/14/2023 due to a decline in the valuation index and volatility index.
D
Sell
2/23/2023Upgraded
MedMira Inc. (MMIRF) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index and volatility index.
MedMira Inc. (MMIRF) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index and volatility index.
D
Sell
2/8/2023Downgrade
MedMira Inc. (MMIRF) was downgraded to D- from D on 2/8/2023 due to a decline in the valuation index and solvency index. The quick ratio declined from 0.1 to 0.1.
MedMira Inc. (MMIRF) was downgraded to D- from D on 2/8/2023 due to a decline in the valuation index and solvency index. The quick ratio declined from 0.1 to 0.1.
D
Sell
12/27/2022Upgraded
MedMira Inc. (MMIRF) was upgraded to D from D- on 12/27/2022 due to an increase in the total return index and valuation index.
MedMira Inc. (MMIRF) was upgraded to D from D- on 12/27/2022 due to an increase in the total return index and valuation index.
D
Sell
11/30/2022Downgrade
MedMira Inc. (MMIRF) was downgraded to D- from D on 11/30/2022 due to a noticeable decline in the total return index and growth index. Total revenue declined 60.95% from $255.8 to $99.9, earnings per share declined from -$0.0005 to -$0.0008, and EBIT declined 36% from -$233.6 to -$317.7.
MedMira Inc. (MMIRF) was downgraded to D- from D on 11/30/2022 due to a noticeable decline in the total return index and growth index. Total revenue declined 60.95% from $255.8 to $99.9, earnings per share declined from -$0.0005 to -$0.0008, and EBIT declined 36% from -$233.6 to -$317.7.
D
Sell
5/31/2022Upgraded
MedMira Inc. (MMIRF) was upgraded to D from D- on 5/31/2022 due to an increase in the total return index.
MedMira Inc. (MMIRF) was upgraded to D from D- on 5/31/2022 due to an increase in the total return index.
D
Sell
5/13/2022Downgrade
MedMira Inc. (MMIRF) was downgraded to D- from D on 5/13/2022 due to a decline in the total return index.
MedMira Inc. (MMIRF) was downgraded to D- from D on 5/13/2022 due to a decline in the total return index.
D
Sell
4/21/2022Upgraded
MedMira Inc. (MMIRF) was upgraded to D from E+ on 04/21/2022.
MedMira Inc. (MMIRF) was upgraded to D from E+ on 04/21/2022.
E
Sell
4/20/2022Downgrade
MedMira Inc. (MMIRF) was downgraded to E+ from D on 4/20/2022 due to a significant decline in the growth index, solvency index and volatility index. Operating cash flow declined 52.88% from -$512.1 to -$782.9, and debt to equity increased from -0.67 to -0.6.
MedMira Inc. (MMIRF) was downgraded to E+ from D on 4/20/2022 due to a significant decline in the growth index, solvency index and volatility index. Operating cash flow declined 52.88% from -$512.1 to -$782.9, and debt to equity increased from -0.67 to -0.6.
D
Sell
11/23/2021Upgraded
MedMira Inc. (MMIRF) was upgraded to D from D- on 11/23/2021 due to an increase in the total return index.
MedMira Inc. (MMIRF) was upgraded to D from D- on 11/23/2021 due to an increase in the total return index.
D
Sell
11/8/2021Downgrade
MedMira Inc. (MMIRF) was downgraded to D- from D on 11/8/2021 due to a substantial decline in the total return index.
MedMira Inc. (MMIRF) was downgraded to D- from D on 11/8/2021 due to a substantial decline in the total return index.
D
Sell
5/1/2020Downgrade
MedMira Inc. (MMIRF) was downgraded to D from C on 5/1/2020 due to a significant decline in the efficiency index and valuation index.
MedMira Inc. (MMIRF) was downgraded to D from C on 5/1/2020 due to a significant decline in the efficiency index and valuation index.
C
Hold
4/22/2020Upgraded
MedMira Inc. (MMIRF) was upgraded to C from C- on 4/22/2020 due to a significant increase in the total return index and growth index. Earnings per share increased from -$0.0008 to -$0.0007, and total revenue increased 7.28% from $67.3 to $72.2.
MedMira Inc. (MMIRF) was upgraded to C from C- on 4/22/2020 due to a significant increase in the total return index and growth index. Earnings per share increased from -$0.0008 to -$0.0007, and total revenue increased 7.28% from $67.3 to $72.2.
C
Hold
12/26/2019Upgraded
MedMira Inc. (MMIRF) was upgraded to C- from D+ on 12/26/2019 due to a noticeable increase in the total return index.
MedMira Inc. (MMIRF) was upgraded to C- from D+ on 12/26/2019 due to a noticeable increase in the total return index.
D
Sell
11/26/2019Upgraded
MedMira Inc. (MMIRF) was upgraded to D+ from D on 11/26/2019 due to an increase in the volatility index and total return index.
MedMira Inc. (MMIRF) was upgraded to D+ from D on 11/26/2019 due to an increase in the volatility index and total return index.
D
Sell
7/26/2019Downgrade
MedMira Inc. (MMIRF) was downgraded to D from D+ on 7/26/2019 due to a decline in the total return index and volatility index.
MedMira Inc. (MMIRF) was downgraded to D from D+ on 7/26/2019 due to a decline in the total return index and volatility index.
D
Sell
6/7/2019Upgraded
MedMira Inc. (MMIRF) was upgraded to D+ from D on 6/7/2019 due to an increase in the total return index and volatility index.
MedMira Inc. (MMIRF) was upgraded to D+ from D on 6/7/2019 due to an increase in the total return index and volatility index.
D
Sell
5/23/2019Downgrade
MedMira Inc. (MMIRF) was downgraded to D from D+ on 5/23/2019 due to a decline in the volatility index and total return index.
MedMira Inc. (MMIRF) was downgraded to D from D+ on 5/23/2019 due to a decline in the volatility index and total return index.
D
Sell
4/23/2019Upgraded
MedMira Inc. (MMIRF) was upgraded to D+ from D on 4/23/2019 due to a significant increase in the efficiency index, growth index and volatility index. Operating cash flow increased 45.74% from -$303.7 to -$164.8, and earnings per share increased from -$0.0008 to -$0.0007.
MedMira Inc. (MMIRF) was upgraded to D+ from D on 4/23/2019 due to a significant increase in the efficiency index, growth index and volatility index. Operating cash flow increased 45.74% from -$303.7 to -$164.8, and earnings per share increased from -$0.0008 to -$0.0007.
D
Sell
12/22/2017Downgrade
MedMira Inc. (MMIRF) was downgraded to D from D+ on 12/22/2017 due to a significant decline in the efficiency index, growth index and solvency index. Operating cash flow declined 92.1% from -$178.4 to -$342.7, earnings per share declined from -$0.0006 to -$0.0008, and EBIT declined 32.84% from -$281.4 to -$373.8.
MedMira Inc. (MMIRF) was downgraded to D from D+ on 12/22/2017 due to a significant decline in the efficiency index, growth index and solvency index. Operating cash flow declined 92.1% from -$178.4 to -$342.7, earnings per share declined from -$0.0006 to -$0.0008, and EBIT declined 32.84% from -$281.4 to -$373.8.
D
Sell
11/29/2017Upgraded
MedMira Inc. (MMIRF) was upgraded to D+ from D- on 11/29/2017 due to a significant increase in the efficiency index, growth index and total return index. Operating cash flow increased 43.78% from -$317.3 to -$178.4, EBIT increased 40.09% from -$469.7 to -$281.4, and earnings per share increased from -$0.0009 to -$0.0006.
MedMira Inc. (MMIRF) was upgraded to D+ from D- on 11/29/2017 due to a significant increase in the efficiency index, growth index and total return index. Operating cash flow increased 43.78% from -$317.3 to -$178.4, EBIT increased 40.09% from -$469.7 to -$281.4, and earnings per share increased from -$0.0009 to -$0.0006.
D
Sell
8/23/2017Downgrade
MedMira Inc. (MMIRF) was downgraded to D- from D on 8/23/2017 due to a noticeable decline in the growth index and solvency index. Earnings per share declined from -$0.0006 to -$0.0009, EBIT declined 46.01% from -$321.7 to -$469.7, and the quick ratio declined from 0.04 to 0.04.
MedMira Inc. (MMIRF) was downgraded to D- from D on 8/23/2017 due to a noticeable decline in the growth index and solvency index. Earnings per share declined from -$0.0006 to -$0.0009, EBIT declined 46.01% from -$321.7 to -$469.7, and the quick ratio declined from 0.04 to 0.04.
D
Sell
3/31/2017Upgraded
MedMira Inc. (MMIRF) was upgraded to D from D- on 3/31/2017 due to a large increase in the growth index. EBIT increased 40.25% from -$538.4 to -$321.7, earnings per share increased from -$0.0009 to -$0.0006, and operating cash flow increased 20.62% from -$519.5 to -$412.4.
MedMira Inc. (MMIRF) was upgraded to D from D- on 3/31/2017 due to a large increase in the growth index. EBIT increased 40.25% from -$538.4 to -$321.7, earnings per share increased from -$0.0009 to -$0.0006, and operating cash flow increased 20.62% from -$519.5 to -$412.4.
D
Sell
12/30/2016Downgrade
MedMira Inc. (MMIRF) was downgraded to D- from D on 12/30/2016 due to a large decline in the growth index, total return index and volatility index. Operating cash flow declined 91.43% from -$272 to -$520.7.
MedMira Inc. (MMIRF) was downgraded to D- from D on 12/30/2016 due to a large decline in the growth index, total return index and volatility index. Operating cash flow declined 91.43% from -$272 to -$520.7.
D
Sell
7/5/2016Upgraded
MedMira Inc. (MMIRF) was upgraded to D from E+ on 7/5/2016 due to a significant increase in the solvency index, growth index and valuation index.
MedMira Inc. (MMIRF) was upgraded to D from E+ on 7/5/2016 due to a significant increase in the solvency index, growth index and valuation index.
E
Sell
6/30/2016Downgrade
MedMira Inc. (MMIRF) was downgraded to E+ from D on 6/30/2016 due to a significant decline in the solvency index, growth index and efficiency index. The quick ratio declined from 0.68 to 0.26.
MedMira Inc. (MMIRF) was downgraded to E+ from D on 6/30/2016 due to a significant decline in the solvency index, growth index and efficiency index. The quick ratio declined from 0.68 to 0.26.
D
Sell
3/28/2016Upgraded
MedMira Inc. (MMIRF) was upgraded to D from D- on 3/28/2016 due to a noticeable increase in the growth index, efficiency index and volatility index. Operating cash flow increased 27.17% from -$1.12M to -$812.3.
MedMira Inc. (MMIRF) was upgraded to D from D- on 3/28/2016 due to a noticeable increase in the growth index, efficiency index and volatility index. Operating cash flow increased 27.17% from -$1.12M to -$812.3.
D
Sell
3/11/2016Downgrade
MedMira Inc. (MMIRF) was downgraded to D- from D on 3/11/2016 due to a major decline in the volatility index and total return index.
MedMira Inc. (MMIRF) was downgraded to D- from D on 3/11/2016 due to a major decline in the volatility index and total return index.
D
Sell
12/15/2015Downgrade
MedMira Inc. (MMIRF) was downgraded to D from C on 12/15/2015 due to a significant decline in the efficiency index, growth index and valuation index. Total capital declined 475.61% from -$575.3 to $2.16M.
MedMira Inc. (MMIRF) was downgraded to D from C on 12/15/2015 due to a significant decline in the efficiency index, growth index and valuation index. Total capital declined 475.61% from -$575.3 to $2.16M.
C
Hold
11/25/2015Upgraded
MedMira Inc. (MMIRF) was upgraded to C from C- on 11/25/2015 due to a significant increase in the efficiency index and valuation index.
MedMira Inc. (MMIRF) was upgraded to C from C- on 11/25/2015 due to a significant increase in the efficiency index and valuation index.
C
Hold
10/28/2015Upgraded
MedMira Inc. (MMIRF) was upgraded to C- from D+ on 10/28/2015 due to an increase in the total return index and volatility index.
MedMira Inc. (MMIRF) was upgraded to C- from D+ on 10/28/2015 due to an increase in the total return index and volatility index.
D
Sell
7/6/2015Downgrade
MedMira Inc. (MMIRF) was downgraded to D+ from C- on 7/6/2015 due to a decline in the total return index.
MedMira Inc. (MMIRF) was downgraded to D+ from C- on 7/6/2015 due to a decline in the total return index.
C
Hold
6/15/2015Upgraded
MedMira Inc. (MMIRF) was upgraded to C- from D+ on 6/15/2015 due to an increase in the growth index and valuation index.
MedMira Inc. (MMIRF) was upgraded to C- from D+ on 6/15/2015 due to an increase in the growth index and valuation index.
D
Sell
5/29/2015Downgrade
MedMira Inc. (MMIRF) was downgraded to D+ from C on 5/29/2015 due to a significant decline in the efficiency index, total return index and solvency index. Net income declined 23.3% from -$890 to -$682.6.
MedMira Inc. (MMIRF) was downgraded to D+ from C on 5/29/2015 due to a significant decline in the efficiency index, total return index and solvency index. Net income declined 23.3% from -$890 to -$682.6.
C
Hold
3/20/2015Upgraded
MedMira Inc. (MMIRF) was upgraded to C from D+ on 3/20/2015 due to a significant increase in the efficiency index, growth index and valuation index. Total capital increased 305.13% from -$202.9 to -$822, total revenue increased 31.56% from $471.5 to $620.3, and EBIT increased 19.85% from -$674 to -$807.8.
MedMira Inc. (MMIRF) was upgraded to C from D+ on 3/20/2015 due to a significant increase in the efficiency index, growth index and valuation index. Total capital increased 305.13% from -$202.9 to -$822, total revenue increased 31.56% from $471.5 to $620.3, and EBIT increased 19.85% from -$674 to -$807.8.
D
Sell
10/13/2014Downgrade
MedMira Inc. (MMIRF) was downgraded to D+ from C- on 10/13/2014 due to a substantial decline in the volatility index and total return index.
MedMira Inc. (MMIRF) was downgraded to D+ from C- on 10/13/2014 due to a substantial decline in the volatility index and total return index.
C
Hold
4/9/2014Upgraded
MedMira Inc. (MMIRF) was upgraded to C- from D on 4/9/2014 due to a noticeable increase in the efficiency index, total return index and solvency index. Net income increased 63.86% from -$809.3 to -$1.33M, and debt to equity declined from -1.64 to -1.2.
MedMira Inc. (MMIRF) was upgraded to C- from D on 4/9/2014 due to a noticeable increase in the efficiency index, total return index and solvency index. Net income increased 63.86% from -$809.3 to -$1.33M, and debt to equity declined from -1.64 to -1.2.
OTC PK
03/10/2025 10:57AM Eastern
Quotes delayed
